Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxi1
|
ENSMUSG00000047861.2 | forkhead box I1 |
Foxo1
|
ENSMUSG00000044167.5 | forkhead box O1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_34207021_34207172 | Foxi1 | 993 | 0.571479 | -0.11 | 3.9e-01 | Click! |
chr11_34206787_34206938 | Foxi1 | 1227 | 0.490805 | -0.10 | 4.3e-01 | Click! |
chr3_52266640_52266927 | Foxo1 | 1553 | 0.270530 | 0.36 | 4.4e-03 | Click! |
chr3_52267643_52268095 | Foxo1 | 467 | 0.690299 | -0.28 | 3.0e-02 | Click! |
chr3_52257866_52258651 | Foxo1 | 10078 | 0.121249 | -0.09 | 5.0e-01 | Click! |
chr3_52266355_52266506 | Foxo1 | 1906 | 0.228126 | 0.05 | 6.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_115817324_115818606 | 7.48 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr2_35334268_35334953 | 5.87 |
Stom |
stomatin |
2366 |
0.21 |
chr5_75377467_75378104 | 5.68 |
Gm22084 |
predicted gene, 22084 |
5640 |
0.2 |
chr19_45445658_45446098 | 5.57 |
Btrc |
beta-transducin repeat containing protein |
370 |
0.86 |
chr9_111055888_111057545 | 4.86 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
530 |
0.62 |
chr15_83169389_83169735 | 4.49 |
Cyb5r3 |
cytochrome b5 reductase 3 |
615 |
0.56 |
chr8_71700550_71701837 | 4.45 |
B3gnt3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
596 |
0.52 |
chr15_66560466_66561298 | 4.44 |
Tmem71 |
transmembrane protein 71 |
221 |
0.94 |
chr10_89532535_89533889 | 4.43 |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
373 |
0.88 |
chr18_62176067_62177775 | 4.40 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chrX_85613609_85614890 | 4.36 |
Gm44378 |
predicted gene, 44378 |
25272 |
0.18 |
chr1_91181340_91182480 | 4.32 |
Ramp1 |
receptor (calcitonin) activity modifying protein 1 |
1864 |
0.27 |
chr5_17848825_17849185 | 4.32 |
Cd36 |
CD36 molecule |
724 |
0.8 |
chr10_22815720_22817074 | 4.24 |
Gm10824 |
predicted gene 10824 |
648 |
0.66 |
chr18_11047852_11049020 | 4.21 |
Gata6os |
GATA binding protein 6, opposite strand |
799 |
0.66 |
chr14_41007005_41008239 | 4.10 |
Prxl2a |
peroxiredoxin like 2A |
644 |
0.68 |
chr10_54072610_54073690 | 4.09 |
Man1a |
mannosidase 1, alpha |
2559 |
0.25 |
chr2_138277835_138280637 | 4.09 |
Btbd3 |
BTB (POZ) domain containing 3 |
743 |
0.81 |
chr9_58656515_58657338 | 4.06 |
Rec114 |
REC114 meiotic recombination protein |
2366 |
0.27 |
chr2_34873990_34875403 | 4.00 |
Cutal |
cutA divalent cation tolerance homolog-like |
178 |
0.6 |
chr10_10184419_10185007 | 3.95 |
4930598N05Rik |
RIKEN cDNA 4930598N05 gene |
87 |
0.96 |
chr6_99094571_99094983 | 3.85 |
Foxp1 |
forkhead box P1 |
1428 |
0.5 |
chr12_99457193_99458078 | 3.83 |
Foxn3 |
forkhead box N3 |
7538 |
0.2 |
chr18_11057575_11058184 | 3.79 |
Gata6 |
GATA binding protein 6 |
1168 |
0.53 |
chr1_136945385_136947968 | 3.77 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
2497 |
0.34 |
chr18_80257995_80258304 | 3.77 |
Slc66a2 |
solute carrier family 66 member 2 |
1831 |
0.22 |
chr2_170147427_170148125 | 3.76 |
Zfp217 |
zinc finger protein 217 |
327 |
0.93 |
chr3_60504423_60505028 | 3.74 |
Mbnl1 |
muscleblind like splicing factor 1 |
3447 |
0.29 |
chr1_153751697_153752752 | 3.74 |
Rnasel |
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
256 |
0.82 |
chr6_116650655_116651088 | 3.71 |
Depp1 |
DEPP1 autophagy regulator |
175 |
0.9 |
chr3_14890853_14891237 | 3.68 |
Car2 |
carbonic anhydrase 2 |
4406 |
0.22 |
chr1_80708717_80710377 | 3.67 |
Dock10 |
dedicator of cytokinesis 10 |
51 |
0.98 |
chr5_139796771_139798844 | 3.67 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
293 |
0.85 |
chr5_147304305_147307985 | 3.66 |
Cdx2 |
caudal type homeobox 2 |
1125 |
0.33 |
chr4_12655171_12655830 | 3.65 |
Gm37985 |
predicted gene, 37985 |
58112 |
0.16 |
chr12_117657998_117660727 | 3.64 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr12_35533032_35533561 | 3.62 |
Gm48236 |
predicted gene, 48236 |
1125 |
0.37 |
chr19_17335214_17335760 | 3.60 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
51 |
0.98 |
chr6_135362982_135365483 | 3.59 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr1_40771505_40772300 | 3.57 |
Gm37915 |
predicted gene, 37915 |
517 |
0.75 |
chr10_99912846_99913873 | 3.56 |
Gm47579 |
predicted gene, 47579 |
47339 |
0.13 |
chr5_64810297_64813272 | 3.56 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr14_101841859_101842332 | 3.56 |
Lmo7 |
LIM domain only 7 |
1276 |
0.57 |
chr8_23035959_23037041 | 3.53 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chr6_34862829_34863673 | 3.44 |
Tmem140 |
transmembrane protein 140 |
11 |
0.96 |
chr3_131364286_131365636 | 3.43 |
Gm43116 |
predicted gene 43116 |
4405 |
0.21 |
chr1_45924247_45924747 | 3.40 |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
765 |
0.56 |
chr17_84180639_84182724 | 3.40 |
Gm36279 |
predicted gene, 36279 |
4075 |
0.18 |
chr17_72921491_72924008 | 3.39 |
Lbh |
limb-bud and heart |
1561 |
0.47 |
chr2_69135753_69136848 | 3.36 |
Nostrin |
nitric oxide synthase trafficker |
500 |
0.81 |
chr19_43985320_43986721 | 3.35 |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
536 |
0.73 |
chr7_25476964_25477300 | 3.34 |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 |
402 |
0.77 |
chr12_110047716_110047968 | 3.34 |
Gm47187 |
predicted gene, 47187 |
14428 |
0.12 |
chr11_48869797_48870455 | 3.32 |
Irgm1 |
immunity-related GTPase family M member 1 |
1248 |
0.29 |
chr3_60473026_60473418 | 3.30 |
Mbnl1 |
muscleblind like splicing factor 1 |
143 |
0.97 |
chr12_32208046_32209200 | 3.29 |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
12 |
0.98 |
chr1_112456627_112457016 | 3.29 |
Gm22331 |
predicted gene, 22331 |
11090 |
0.28 |
chr4_154024404_154026596 | 3.27 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chr7_120979495_120980366 | 3.26 |
Cdr2 |
cerebellar degeneration-related 2 |
1860 |
0.19 |
chr3_142496513_142497790 | 3.24 |
Gbp5 |
guanylate binding protein 5 |
209 |
0.93 |
chr6_72379584_72380121 | 3.24 |
Vamp5 |
vesicle-associated membrane protein 5 |
570 |
0.58 |
chr16_42907917_42908393 | 3.24 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
503 |
0.78 |
chr10_122029388_122030087 | 3.23 |
Srgap1 |
SLIT-ROBO Rho GTPase activating protein 1 |
17571 |
0.15 |
chr5_5261065_5262223 | 3.23 |
Cdk14 |
cyclin-dependent kinase 14 |
3665 |
0.25 |
chr7_97749255_97749938 | 3.23 |
Aqp11 |
aquaporin 11 |
11307 |
0.16 |
chr10_54070413_54070980 | 3.22 |
Man1a |
mannosidase 1, alpha |
5013 |
0.2 |
chr8_14889830_14890194 | 3.21 |
Cln8 |
CLN8 transmembrane ER and ERGIC protein |
653 |
0.71 |
chr9_14378940_14379551 | 3.21 |
Endod1 |
endonuclease domain containing 1 |
1738 |
0.24 |
chr7_100465236_100467118 | 3.18 |
C2cd3 |
C2 calcium-dependent domain containing 3 |
770 |
0.37 |
chr7_83654607_83655449 | 3.17 |
Il16 |
interleukin 16 |
297 |
0.84 |
chr5_43869783_43870400 | 3.17 |
Cd38 |
CD38 antigen |
1231 |
0.3 |
chr3_98280903_98281615 | 3.17 |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 |
824 |
0.54 |
chr15_8967409_8968940 | 3.14 |
Ranbp3l |
RAN binding protein 3-like |
172 |
0.96 |
chr7_19290671_19291896 | 3.14 |
Rtn2 |
reticulon 2 (Z-band associated protein) |
214 |
0.83 |
chr1_51288641_51290950 | 3.12 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr11_49087855_49088820 | 3.11 |
Ifi47 |
interferon gamma inducible protein 47 |
73 |
0.66 |
chr14_25480994_25481876 | 3.10 |
Gm47921 |
predicted gene, 47921 |
1381 |
0.34 |
chr9_107298004_107299417 | 3.08 |
Cish |
cytokine inducible SH2-containing protein |
445 |
0.63 |
chr10_93688782_93689243 | 3.07 |
Gm15915 |
predicted gene 15915 |
5690 |
0.15 |
chr1_88407096_88408235 | 3.05 |
Spp2 |
secreted phosphoprotein 2 |
259 |
0.91 |
chr2_103961078_103961229 | 3.04 |
Lmo2 |
LIM domain only 2 |
3158 |
0.19 |
chr16_92824962_92826063 | 3.04 |
Runx1 |
runt related transcription factor 1 |
266 |
0.94 |
chr4_11146992_11147797 | 3.00 |
Gm11830 |
predicted gene 11830 |
2684 |
0.17 |
chr17_40811481_40812037 | 2.99 |
Rhag |
Rhesus blood group-associated A glycoprotein |
575 |
0.7 |
chr9_105520039_105521535 | 2.99 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr2_163641826_163642055 | 2.97 |
0610039K10Rik |
RIKEN cDNA 0610039K10 gene |
2910 |
0.17 |
chr16_95456632_95459094 | 2.95 |
Erg |
ETS transcription factor |
1382 |
0.55 |
chr15_58324214_58324553 | 2.95 |
Klhl38 |
kelch-like 38 |
214 |
0.94 |
chr11_83849571_83850989 | 2.95 |
Hnf1b |
HNF1 homeobox B |
217 |
0.83 |
chr7_110980845_110981452 | 2.90 |
Mrvi1 |
MRV integration site 1 |
910 |
0.59 |
chr2_173024069_173026002 | 2.89 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr4_57914999_57916744 | 2.89 |
D630039A03Rik |
RIKEN cDNA D630039A03 gene |
426 |
0.84 |
chr3_140837894_140838045 | 2.89 |
Gm6214 |
predicted gene 6214 |
1668 |
0.4 |
chr14_51130108_51130570 | 2.89 |
Rnase6 |
ribonuclease, RNase A family, 6 |
1258 |
0.24 |
chr13_5845041_5845796 | 2.88 |
1700016G22Rik |
RIKEN cDNA 1700016G22 gene |
12143 |
0.16 |
chr3_14888603_14889051 | 2.86 |
Car2 |
carbonic anhydrase 2 |
2188 |
0.31 |
chr1_136957653_136959179 | 2.85 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
1964 |
0.38 |
chr2_64930439_64930859 | 2.85 |
Grb14 |
growth factor receptor bound protein 14 |
3793 |
0.33 |
chr9_50692780_50693781 | 2.84 |
Dixdc1 |
DIX domain containing 1 |
519 |
0.7 |
chr10_68135346_68136945 | 2.84 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
481 |
0.87 |
chr1_34123372_34123844 | 2.84 |
Dst |
dystonin |
2358 |
0.27 |
chr1_37664681_37665227 | 2.83 |
4930470B04Rik |
RIKEN cDNA 4930470B04 gene |
4232 |
0.2 |
chr10_79706079_79708046 | 2.82 |
Bsg |
basigin |
2492 |
0.11 |
chr10_93682908_93683409 | 2.82 |
Gm15915 |
predicted gene 15915 |
164 |
0.94 |
chr7_143007094_143009025 | 2.82 |
Tspan32os |
tetraspanin 32, opposite strand |
26 |
0.96 |
chr18_62174392_62175675 | 2.81 |
Adrb2 |
adrenergic receptor, beta 2 |
4926 |
0.21 |
chr14_55061871_55064122 | 2.80 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chr12_69757617_69759559 | 2.79 |
Mir681 |
microRNA 681 |
5356 |
0.14 |
chr1_172990325_172991090 | 2.79 |
Olfr16 |
olfactory receptor 16 |
33939 |
0.13 |
chr19_43985153_43985304 | 2.79 |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
1328 |
0.38 |
chr9_103286971_103287430 | 2.76 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
1024 |
0.5 |
chr1_74000936_74001518 | 2.75 |
Tns1 |
tensin 1 |
340 |
0.91 |
chr12_78863892_78864556 | 2.74 |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
2094 |
0.25 |
chr5_137531422_137533165 | 2.74 |
Gm17112 |
predicted gene 17112 |
130 |
0.69 |
chr15_55121143_55121787 | 2.74 |
Gm9920 |
predicted gene 9920 |
7788 |
0.16 |
chr12_13180179_13180570 | 2.73 |
Gm24208 |
predicted gene, 24208 |
16611 |
0.16 |
chr1_88482217_88482931 | 2.71 |
Gm29538 |
predicted gene 29538 |
19966 |
0.14 |
chr16_93591518_93591669 | 2.71 |
Gm49961 |
predicted gene, 49961 |
192 |
0.77 |
chr7_115859429_115859864 | 2.70 |
Sox6 |
SRY (sex determining region Y)-box 6 |
206 |
0.97 |
chr18_5603232_5604403 | 2.70 |
Zeb1 |
zinc finger E-box binding homeobox 1 |
73 |
0.96 |
chr1_125676834_125678312 | 2.68 |
Gpr39 |
G protein-coupled receptor 39 |
578 |
0.8 |
chr7_75613990_75614480 | 2.68 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
453 |
0.84 |
chr5_108674592_108675616 | 2.68 |
Slc26a1 |
solute carrier family 26 (sulfate transporter), member 1 |
319 |
0.8 |
chr3_129331827_129332986 | 2.68 |
Enpep |
glutamyl aminopeptidase |
142 |
0.95 |
chr1_34120973_34122005 | 2.67 |
Dst |
dystonin |
239 |
0.92 |
chr6_136857054_136858156 | 2.66 |
Art4 |
ADP-ribosyltransferase 4 |
128 |
0.92 |
chr11_8502774_8504068 | 2.63 |
Tns3 |
tensin 3 |
34746 |
0.23 |
chr10_109136999_109137537 | 2.62 |
Syt1 |
synaptotagmin I |
126286 |
0.06 |
chr7_45523041_45524800 | 2.62 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
151 |
0.85 |
chr9_5308602_5309732 | 2.62 |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
302 |
0.91 |
chr8_18738571_18739759 | 2.61 |
Angpt2 |
angiopoietin 2 |
2397 |
0.3 |
chr6_67161907_67162479 | 2.61 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
2731 |
0.23 |
chr19_10015065_10016667 | 2.61 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr16_44015370_44016774 | 2.60 |
Gramd1c |
GRAM domain containing 1C |
364 |
0.83 |
chr8_24351673_24352600 | 2.58 |
Gm45164 |
predicted gene 45164 |
7300 |
0.22 |
chr16_91805843_91806547 | 2.58 |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
1559 |
0.38 |
chr6_99095299_99096526 | 2.57 |
Foxp1 |
forkhead box P1 |
293 |
0.93 |
chr3_127931051_127931375 | 2.57 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
15041 |
0.14 |
chr7_104244475_104245215 | 2.56 |
Trim34a |
tripartite motif-containing 34A |
352 |
0.71 |
chr11_102360845_102363484 | 2.56 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr13_98944722_98944935 | 2.56 |
Gm35215 |
predicted gene, 35215 |
1088 |
0.4 |
chr18_75384437_75388058 | 2.56 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr19_46623097_46624579 | 2.55 |
Wbp1l |
WW domain binding protein 1 like |
437 |
0.77 |
chr3_98761693_98762033 | 2.55 |
Hsd3b3 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 |
541 |
0.7 |
chr19_20600997_20601809 | 2.55 |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
558 |
0.79 |
chr4_115057577_115059724 | 2.54 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
839 |
0.56 |
chr8_60981765_60981966 | 2.52 |
Clcn3 |
chloride channel, voltage-sensitive 3 |
1374 |
0.3 |
chr11_98448535_98449780 | 2.51 |
Grb7 |
growth factor receptor bound protein 7 |
2089 |
0.15 |
chr6_127246090_127246322 | 2.50 |
Gm43635 |
predicted gene 43635 |
8438 |
0.13 |
chr1_40224749_40225907 | 2.48 |
Il1r1 |
interleukin 1 receptor, type I |
248 |
0.93 |
chr10_79417219_79417524 | 2.48 |
Gm47015 |
predicted gene, 47015 |
534 |
0.77 |
chr5_110836247_110836790 | 2.48 |
Hscb |
HscB iron-sulfur cluster co-chaperone |
198 |
0.9 |
chr5_105757977_105758285 | 2.47 |
Lrrc8d |
leucine rich repeat containing 8D |
25901 |
0.16 |
chr18_60500309_60500522 | 2.46 |
Smim3 |
small integral membrane protein 3 |
1161 |
0.44 |
chr1_97802358_97802693 | 2.46 |
Pam |
peptidylglycine alpha-amidating monooxygenase |
23460 |
0.16 |
chr4_127311434_127313205 | 2.46 |
Gja4 |
gap junction protein, alpha 4 |
1720 |
0.26 |
chr2_20736484_20738247 | 2.45 |
Etl4 |
enhancer trap locus 4 |
51 |
0.98 |
chr6_144961455_144962096 | 2.44 |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
71068 |
0.08 |
chr15_103253562_103255772 | 2.44 |
Nfe2 |
nuclear factor, erythroid derived 2 |
605 |
0.57 |
chr1_156615340_156616247 | 2.44 |
Abl2 |
v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene) |
130 |
0.96 |
chr5_72224662_72225245 | 2.43 |
Atp10d |
ATPase, class V, type 10D |
21600 |
0.17 |
chr19_5847515_5849685 | 2.43 |
Frmd8os |
FERM domain containing 8, opposite strand |
92 |
0.92 |
chr6_60826003_60826617 | 2.43 |
Snca |
synuclein, alpha |
1246 |
0.48 |
chr1_74295387_74296968 | 2.42 |
Tmbim1 |
transmembrane BAX inhibitor motif containing 1 |
482 |
0.41 |
chr1_134075582_134077148 | 2.42 |
Btg2 |
BTG anti-proliferation factor 2 |
2755 |
0.19 |
chr5_107874374_107875235 | 2.41 |
Evi5 |
ecotropic viral integration site 5 |
240 |
0.86 |
chr13_4278761_4279470 | 2.41 |
Akr1c12 |
aldo-keto reductase family 1, member C12 |
318 |
0.87 |
chr2_60939895_60940920 | 2.41 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22785 |
0.21 |
chr8_82400401_82400776 | 2.40 |
Il15 |
interleukin 15 |
1245 |
0.53 |
chr19_5660333_5662014 | 2.39 |
Sipa1 |
signal-induced proliferation associated gene 1 |
462 |
0.59 |
chr5_144355798_144356558 | 2.38 |
Dmrt1i |
Dmrt1 interacting ncRNA |
1745 |
0.28 |
chr16_52060234_52061054 | 2.37 |
Cblb |
Casitas B-lineage lymphoma b |
10991 |
0.24 |
chr18_32557788_32558922 | 2.36 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr11_79523074_79523258 | 2.36 |
Evi2b |
ecotropic viral integration site 2b |
596 |
0.59 |
chr11_116782685_116783105 | 2.36 |
St6galnac1 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 |
7388 |
0.12 |
chr5_48509434_48509944 | 2.36 |
Kcnip4 |
Kv channel interacting protein 4 |
17425 |
0.18 |
chr15_76242501_76243437 | 2.36 |
Parp10 |
poly (ADP-ribose) polymerase family, member 10 |
451 |
0.59 |
chr3_14890597_14890760 | 2.35 |
Car2 |
carbonic anhydrase 2 |
4039 |
0.23 |
chr15_40168354_40168505 | 2.35 |
Gm33301 |
predicted gene, 33301 |
5822 |
0.2 |
chr14_27562590_27562831 | 2.35 |
Gm7604 |
predicted gene 7604 |
10552 |
0.18 |
chr1_125432541_125433711 | 2.35 |
Actr3 |
ARP3 actin-related protein 3 |
1520 |
0.47 |
chr11_110094976_110095336 | 2.34 |
Abca8a |
ATP-binding cassette, sub-family A (ABC1), member 8a |
781 |
0.73 |
chr9_72913422_72914272 | 2.34 |
Prtg |
protogenin |
3220 |
0.13 |
chr10_15759734_15760317 | 2.34 |
Gm40604 |
predicted gene, 40604 |
13 |
0.98 |
chr13_73262153_73264451 | 2.34 |
Irx4 |
Iroquois homeobox 4 |
2805 |
0.22 |
chr8_85380167_85381092 | 2.34 |
Mylk3 |
myosin light chain kinase 3 |
349 |
0.83 |
chr6_87809573_87810010 | 2.34 |
Rab43 |
RAB43, member RAS oncogene family |
34 |
0.93 |
chr10_94919221_94919453 | 2.34 |
Plxnc1 |
plexin C1 |
3320 |
0.26 |
chr18_65393136_65393441 | 2.33 |
Alpk2 |
alpha-kinase 2 |
606 |
0.6 |
chr19_17350568_17350960 | 2.33 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
5903 |
0.24 |
chr12_35532487_35532918 | 2.33 |
Gm48236 |
predicted gene, 48236 |
1719 |
0.29 |
chr18_20665217_20665731 | 2.32 |
Ttr |
transthyretin |
194 |
0.52 |
chr11_98581976_98582749 | 2.32 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
5006 |
0.11 |
chr18_62178016_62178230 | 2.32 |
Adrb2 |
adrenergic receptor, beta 2 |
1836 |
0.3 |
chr7_25626920_25628374 | 2.32 |
B3gnt8 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
5 |
0.94 |
chr11_107454658_107455533 | 2.32 |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
15604 |
0.11 |
chr12_113141740_113143605 | 2.31 |
Crip2 |
cysteine rich protein 2 |
136 |
0.92 |
chr2_169723539_169724473 | 2.31 |
Tshz2 |
teashirt zinc finger family member 2 |
90330 |
0.08 |
chr4_123613126_123613703 | 2.31 |
Macf1 |
microtubule-actin crosslinking factor 1 |
329 |
0.85 |
chr4_135727528_135728972 | 2.31 |
Il22ra1 |
interleukin 22 receptor, alpha 1 |
78 |
0.96 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.3 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.1 | 9.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.0 | 6.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
2.0 | 5.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.0 | 5.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.7 | 5.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.7 | 8.3 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.6 | 4.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.6 | 4.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.6 | 4.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.6 | 4.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.6 | 4.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.5 | 4.6 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.5 | 4.6 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.5 | 6.1 | GO:0003166 | bundle of His development(GO:0003166) |
1.4 | 7.1 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.4 | 1.4 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
1.3 | 1.3 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
1.3 | 5.2 | GO:0032264 | IMP salvage(GO:0032264) |
1.2 | 4.9 | GO:1900211 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
1.2 | 4.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.2 | 3.7 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
1.2 | 4.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.2 | 2.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.2 | 3.5 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.2 | 3.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.1 | 3.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.1 | 3.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.1 | 4.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.1 | 5.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.1 | 2.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.1 | 5.3 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.0 | 5.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.0 | 3.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.0 | 3.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.0 | 4.1 | GO:0050904 | diapedesis(GO:0050904) |
1.0 | 5.0 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.0 | 2.9 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.0 | 8.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.0 | 2.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.0 | 1.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.0 | 1.0 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.9 | 3.7 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.9 | 2.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.9 | 3.6 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.9 | 3.6 | GO:0008228 | opsonization(GO:0008228) |
0.9 | 1.8 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.9 | 2.7 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.9 | 2.7 | GO:0035483 | gastric emptying(GO:0035483) |
0.9 | 2.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.9 | 2.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.9 | 3.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.9 | 5.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.9 | 2.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 2.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.8 | 4.1 | GO:0033007 | negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
0.8 | 3.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.8 | 2.4 | GO:0061010 | gall bladder development(GO:0061010) |
0.8 | 2.4 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.8 | 5.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.8 | 0.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.8 | 2.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.8 | 1.6 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.8 | 4.7 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.8 | 3.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.8 | 3.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.8 | 2.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.8 | 5.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.8 | 1.6 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.8 | 1.5 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.8 | 1.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.7 | 3.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.7 | 3.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.7 | 0.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.7 | 2.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.7 | 3.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.7 | 1.5 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.7 | 2.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.7 | 0.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.7 | 1.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.7 | 0.7 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.7 | 4.9 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.7 | 2.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.7 | 1.4 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.7 | 1.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.7 | 2.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.7 | 3.4 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.7 | 2.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.7 | 2.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.7 | 0.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.7 | 2.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.7 | 3.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.7 | 2.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.7 | 2.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 13.9 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.7 | 5.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.7 | 2.0 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 1.9 | GO:0070836 | caveola assembly(GO:0070836) |
0.6 | 0.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.6 | 2.6 | GO:0006848 | pyruvate transport(GO:0006848) |
0.6 | 3.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.6 | 1.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 1.9 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.6 | 5.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.6 | 0.6 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.6 | 0.6 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.6 | 5.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.6 | 1.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.6 | 1.9 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.6 | 0.6 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.6 | 2.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.6 | 3.0 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 2.9 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.6 | 1.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 1.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.6 | 1.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.6 | 2.9 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.6 | 2.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.6 | 1.7 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.6 | 1.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.6 | 1.7 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.6 | 2.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.6 | 1.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 3.4 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.6 | 1.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 0.6 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.6 | 1.7 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.6 | 4.5 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.6 | 1.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 1.7 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.6 | 2.8 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.6 | 1.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.6 | 1.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.6 | 1.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 2.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.6 | 1.7 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.5 | 2.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.5 | 1.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.5 | 1.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.5 | 1.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.5 | 4.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 14.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 1.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.5 | 3.2 | GO:0015677 | copper ion import(GO:0015677) |
0.5 | 3.2 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.5 | 1.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.5 | 1.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.5 | 1.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.5 | 3.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.5 | 2.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.5 | 1.6 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.5 | 1.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.5 | 1.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.5 | 1.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.5 | 1.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 1.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.5 | 1.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.5 | 1.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.5 | 3.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 3.4 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 1.0 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.5 | 1.9 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 1.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.5 | 1.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 1.4 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.5 | 1.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 1.4 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.5 | 2.4 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.5 | 0.9 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.5 | 0.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.5 | 5.6 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.5 | 2.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.5 | 0.9 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.5 | 5.5 | GO:0010226 | response to lithium ion(GO:0010226) |
0.5 | 0.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.5 | 1.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.5 | 0.9 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 2.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.5 | 2.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 1.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.4 | 1.8 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 0.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 0.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.4 | 0.9 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.4 | 1.7 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 1.3 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 1.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.4 | 0.4 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 0.4 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.4 | 1.7 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.4 | 1.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.4 | 0.8 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.4 | 1.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.4 | 0.4 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.4 | 1.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.4 | 2.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 2.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.4 | 1.7 | GO:0007567 | parturition(GO:0007567) |
0.4 | 0.8 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.4 | 0.8 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.4 | 1.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 1.6 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.4 | 1.2 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 1.6 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.4 | 2.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 3.6 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.4 | 0.4 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.4 | 0.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.4 | 3.1 | GO:0030449 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.4 | 1.6 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.4 | 0.8 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.4 | 4.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 1.6 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.4 | 0.8 | GO:0010159 | specification of organ position(GO:0010159) |
0.4 | 1.2 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.4 | 1.2 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.4 | 1.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.4 | 1.9 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.4 | 1.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 0.8 | GO:0036394 | amylase secretion(GO:0036394) |
0.4 | 0.8 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 1.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 0.4 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.4 | 1.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.4 | 6.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 0.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 1.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 1.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.4 | 0.4 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.4 | 2.9 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.4 | 1.1 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.4 | 2.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.4 | 1.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.4 | 0.7 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) regulation of type B pancreatic cell apoptotic process(GO:2000674) negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.4 | 3.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 0.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.4 | 1.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 0.7 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.4 | 1.4 | GO:0046618 | drug export(GO:0046618) |
0.4 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 1.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 0.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.3 | 0.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.3 | 1.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.3 | 1.7 | GO:0019627 | urea metabolic process(GO:0019627) |
0.3 | 2.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 1.4 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.3 | 3.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.3 | 0.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 1.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 1.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 8.3 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.3 | 2.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 0.3 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.3 | 1.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.3 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.3 | 1.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 1.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 0.3 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.3 | 1.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 2.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 1.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 0.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 0.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 2.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 1.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 1.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 0.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 2.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.3 | 0.9 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 1.9 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.3 | 1.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.3 | 1.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 2.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.3 | 0.3 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.3 | 2.8 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.3 | 2.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 1.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 0.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.3 | 1.2 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.3 | 0.3 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.3 | 0.3 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.3 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 9.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 2.1 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 1.5 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.3 | 0.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 0.6 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 1.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.3 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 0.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 0.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 0.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 0.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 5.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 7.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 0.9 | GO:0008050 | female courtship behavior(GO:0008050) |
0.3 | 1.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 1.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.3 | 0.3 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.3 | 0.6 | GO:0070668 | negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.3 | 5.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 4.3 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 2.6 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 2.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.3 | 0.6 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 0.6 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.3 | 0.9 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
0.3 | 1.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 0.3 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 0.8 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.3 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 0.8 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 0.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.3 | 0.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.3 | 0.6 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) negative regulation of aldosterone metabolic process(GO:0032345) regulation of aldosterone biosynthetic process(GO:0032347) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.3 | 1.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 0.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 0.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 0.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 0.3 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.3 | 0.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 1.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 3.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 3.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 2.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 3.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 0.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 0.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.3 | 1.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 6.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 1.9 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 1.6 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 0.3 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.3 | 0.5 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 1.3 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.3 | 0.5 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 0.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.3 | 0.8 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 0.8 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.3 | 2.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 0.8 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 1.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 0.8 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.3 | 1.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 1.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 0.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 0.8 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.3 | 0.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.3 | 0.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 0.8 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 0.8 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.3 | 0.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 1.8 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 3.6 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.3 | 1.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 2.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 0.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 1.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 0.3 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.3 | 0.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.3 | 0.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.7 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 1.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 1.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 1.0 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.2 | 0.7 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.2 | 2.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 1.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 1.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 1.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.2 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.2 | 1.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.2 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 4.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.2 | 0.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.2 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 1.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 1.2 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.2 | 0.5 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.2 | 0.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.2 | 1.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 1.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 0.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 1.9 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 0.9 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.2 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 2.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.7 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 0.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 0.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 1.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 2.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 1.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 1.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 1.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 0.9 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 0.7 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.7 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 1.3 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.2 | 1.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.7 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.2 | 0.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 5.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 1.3 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 0.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 1.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.2 | 1.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.2 | 0.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 0.6 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.2 | 0.2 | GO:0036507 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 1.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 1.9 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 0.8 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 2.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.2 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 0.6 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.6 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 1.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 2.7 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.2 | 3.9 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 1.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.6 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.2 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.2 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.8 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 2.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.6 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.2 | GO:0035482 | gastric motility(GO:0035482) |
0.2 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.2 | 0.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.2 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 1.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.4 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.2 | 1.8 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 1.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 0.2 | GO:0043373 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
0.2 | 0.4 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.2 | 0.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 1.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 1.3 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.2 | 0.6 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.6 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 3.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.4 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 0.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.6 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.2 | 3.4 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 0.7 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 0.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.4 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 1.5 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 0.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.2 | 0.7 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 2.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.2 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.2 | 0.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.5 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 2.0 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.4 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 0.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 0.2 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.2 | 2.0 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.2 | 0.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.2 | 0.4 | GO:0051197 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 0.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 1.2 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.2 | 0.9 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 1.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 3.5 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 0.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.4 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 0.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.3 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.2 | 0.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 2.4 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 1.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 1.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 2.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 1.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.3 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 2.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 1.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 1.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.5 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 4.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 0.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.2 | 1.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.2 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 1.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 1.3 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.2 | 0.8 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.5 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.2 | 0.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 1.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.6 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.2 | 0.5 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.2 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 1.4 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.5 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.2 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 4.1 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.6 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.3 | GO:0042737 | drug catabolic process(GO:0042737) |
0.2 | 1.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 0.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.2 | 2.2 | GO:0045123 | cellular extravasation(GO:0045123) |
0.2 | 0.3 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.2 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 0.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.8 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.2 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 1.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 2.9 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.2 | 2.9 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 0.3 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.6 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.2 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 1.0 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.6 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.1 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.7 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 1.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 2.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.9 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 1.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.3 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.9 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 2.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.4 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
0.1 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.9 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.1 | 1.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.6 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.1 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.1 | 1.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.7 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 1.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.3 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.7 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.7 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 1.6 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.4 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 1.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 1.6 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.3 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.9 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.3 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 1.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.5 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 1.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.5 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.6 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.1 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 0.5 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.6 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.1 | 0.6 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.3 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 2.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 1.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.4 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.1 | 0.4 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.5 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 1.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.6 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 1.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.4 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 1.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 2.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.2 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.5 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 1.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 1.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.3 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.1 | 1.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.2 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 1.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 1.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.3 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.1 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.1 | 2.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 1.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 1.0 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.5 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 1.1 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 1.4 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 1.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.9 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.4 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.5 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 1.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 1.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 3.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.8 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 2.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 1.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 1.2 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.1 | 0.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.4 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 1.0 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 1.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.5 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.3 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.1 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 4.5 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 1.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 1.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.4 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.5 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.2 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.9 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.1 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 6.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 3.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.3 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.4 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.5 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.1 | 0.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.1 | 1.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.8 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 1.2 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 0.1 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.1 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 1.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.4 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.1 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.2 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.7 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.1 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.1 | 0.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.1 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.1 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.5 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.3 | GO:1902402 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.1 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.1 | 1.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 1.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.5 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.7 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.6 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 0.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.1 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.1 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.2 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.1 | 0.1 | GO:2000343 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.1 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 1.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.4 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.1 | GO:0045078 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.5 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) cellular response to leptin stimulus(GO:0044320) |
0.1 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.3 | GO:0002664 | regulation of T cell tolerance induction(GO:0002664) |
0.1 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 2.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 0.1 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.4 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.9 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.1 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 2.1 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 1.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.2 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.1 | 0.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.2 | GO:0048241 | epinephrine transport(GO:0048241) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.3 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.5 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.5 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.3 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.1 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.0 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.0 | 0.2 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 3.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.0 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.0 | 0.2 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.0 | 0.3 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.4 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 1.2 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.0 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.0 | 0.0 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 1.0 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.0 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.0 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.0 | 0.0 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.0 | 0.0 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.0 | 0.4 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 1.0 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.2 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.7 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity(GO:2001056) |
0.0 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.0 | 0.0 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 1.1 | GO:0007596 | blood coagulation(GO:0007596) |
0.0 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.5 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.0 | 0.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.3 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 1.7 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.6 | GO:0033141 | natural killer cell activation involved in immune response(GO:0002323) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.0 | GO:0048143 | astrocyte activation(GO:0048143) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.0 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.0 | 0.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.0 | 0.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.0 | 0.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.0 | GO:1904749 | protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.0 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.0 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.0 | 13.6 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.0 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 0.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.3 | GO:0009988 | cell-cell recognition(GO:0009988) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 6.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.2 | 3.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.2 | 3.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.0 | 9.4 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
1.0 | 6.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.0 | 1.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.9 | 3.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.9 | 4.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.8 | 5.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 5.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 4.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 2.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.7 | 4.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 3.1 | GO:0008091 | spectrin(GO:0008091) |
0.6 | 4.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 2.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.6 | 8.7 | GO:0031430 | M band(GO:0031430) |
0.5 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 1.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.5 | 2.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 0.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 1.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 2.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 1.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.5 | 2.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.5 | 0.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 3.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 1.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 4.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 2.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 1.6 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.4 | 1.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 2.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 2.1 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 0.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 2.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 3.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 2.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 1.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 0.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 4.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 1.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 4.2 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 1.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 1.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 0.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 1.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 2.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 9.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 0.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.3 | 3.0 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 1.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.3 | 2.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 3.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 0.3 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.3 | 1.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 1.7 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 4.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 0.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 4.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 22.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 2.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 3.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 0.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 1.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 3.9 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 0.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 2.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 2.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 1.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 2.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 2.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 1.7 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 1.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 5.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 8.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 11.8 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.8 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.2 | 0.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 9.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 2.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 0.2 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
0.2 | 2.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 7.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 1.0 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 3.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.5 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.8 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 0.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 0.5 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 0.9 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 2.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 7.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.3 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 1.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 2.4 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 1.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 3.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 1.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 1.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 2.6 | GO:0005903 | brush border(GO:0005903) |
0.1 | 1.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.9 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 1.2 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 1.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 1.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 1.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 3.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.5 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 1.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 4.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.6 | GO:0005818 | aster(GO:0005818) |
0.1 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 1.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 1.0 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 1.4 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 5.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 11.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 10.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 1.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.5 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 7.9 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 3.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.6 | GO:0031672 | A band(GO:0031672) |
0.1 | 2.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 3.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.2 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 13.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 0.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 3.9 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 3.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 2.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 2.7 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 1.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.2 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 0.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 17.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.2 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.1 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 2.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.6 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.7 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.0 | 0.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 3.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.4 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 0.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 2.0 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 4.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 5.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 2.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 3.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 6.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 73.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 1.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 1.7 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.5 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 1.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 1.3 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 21.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.6 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 1.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.4 | GO:0044298 | cell body membrane(GO:0044298) |
0.0 | 0.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.7 | GO:0005814 | centriole(GO:0005814) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 12.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.7 | 8.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.4 | 7.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.8 | 5.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.7 | 10.1 | GO:0004064 | arylesterase activity(GO:0004064) |
1.7 | 5.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.6 | 6.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.6 | 4.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.5 | 1.5 | GO:0019808 | polyamine binding(GO:0019808) |
1.4 | 4.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.3 | 4.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.1 | 3.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.1 | 4.2 | GO:0031433 | telethonin binding(GO:0031433) |
1.1 | 5.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.0 | 4.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.0 | 5.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.0 | 4.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.9 | 2.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.9 | 3.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.9 | 1.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.9 | 2.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.9 | 3.5 | GO:0015265 | urea channel activity(GO:0015265) |
0.8 | 4.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.8 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.8 | 4.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.8 | 2.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.8 | 2.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 5.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 3.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.7 | 4.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.7 | 3.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.7 | 1.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.7 | 2.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.7 | 1.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.7 | 3.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 3.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.7 | 2.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.7 | 3.4 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.7 | 2.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.7 | 2.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.7 | 2.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.7 | 8.6 | GO:0016208 | AMP binding(GO:0016208) |
0.6 | 5.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.6 | 3.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.6 | 2.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 3.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.6 | 1.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 11.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.6 | 2.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 4.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.6 | 3.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 2.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.6 | 1.8 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.6 | 1.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.6 | 4.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 1.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.6 | 2.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.6 | 2.3 | GO:0009374 | biotin binding(GO:0009374) |
0.6 | 5.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.6 | 3.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 1.1 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.6 | 1.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.6 | 2.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.6 | 1.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.5 | 2.2 | GO:0070061 | fructose binding(GO:0070061) |
0.5 | 3.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 2.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 1.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 1.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 2.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 1.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 1.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 1.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.5 | 1.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 3.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.5 | 2.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 1.9 | GO:0001846 | opsonin binding(GO:0001846) |
0.5 | 1.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.5 | 3.3 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 2.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 4.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.5 | 3.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.5 | 1.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 4.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 1.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 1.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 1.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 2.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 2.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 3.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 1.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 2.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 2.6 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 0.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 1.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 0.8 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.4 | 1.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 1.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 0.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 4.8 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 2.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 1.6 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 5.9 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 1.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 2.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 1.9 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 10.1 | GO:0042805 | actinin binding(GO:0042805) |
0.4 | 1.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.4 | 0.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 1.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 12.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 1.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 2.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 0.4 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.4 | 1.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 2.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.4 | 6.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 0.4 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 1.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 3.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 1.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.3 | 2.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 1.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 2.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 1.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 0.7 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 1.3 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 2.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 0.3 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.3 | 1.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 1.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 0.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 0.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 1.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 1.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 0.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 0.9 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 2.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 1.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 0.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 1.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 2.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 1.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 0.3 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.3 | 0.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 5.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 0.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 0.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 3.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 0.9 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.3 | 5.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 2.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 1.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 0.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 2.2 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 2.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 2.5 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 0.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 0.8 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 0.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 1.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 1.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 10.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 5.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 3.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 1.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 1.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 1.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 1.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.8 | GO:0051379 | epinephrine binding(GO:0051379) |
0.3 | 0.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 0.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.5 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 1.0 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 1.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 0.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 7.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 3.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 4.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 0.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 0.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 1.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 2.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 4.6 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.9 | GO:0034560 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
0.2 | 6.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 2.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.9 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 0.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 2.6 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.2 | 0.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 1.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 1.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 1.3 | GO:0034805 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.6 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 0.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 1.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 1.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 2.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 2.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 1.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 2.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 1.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 0.6 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.9 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 0.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 3.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 2.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.9 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 4.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 1.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 0.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 1.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 2.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 1.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 4.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.5 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 0.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.7 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 2.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 1.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 1.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 2.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 10.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.2 | 0.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 10.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 2.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.5 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 0.5 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 2.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 1.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 0.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.5 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 0.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 2.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 2.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 1.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 1.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.8 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 1.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 1.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 1.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.9 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 6.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 3.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 2.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 1.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 2.4 | GO:0046915 | zinc ion transmembrane transporter activity(GO:0005385) transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 0.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 2.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 1.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 1.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 13.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 1.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.9 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 1.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 1.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.9 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 1.0 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 2.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 1.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 1.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 3.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.4 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 6.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 1.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 2.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 1.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 1.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.6 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.3 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 1.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 1.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 3.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 1.7 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 1.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.3 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 1.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 2.8 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 1.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 2.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 1.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 2.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 6.5 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.7 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 2.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.8 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 4.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.1 | 1.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 2.2 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.1 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.7 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 2.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 2.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 2.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.9 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 1.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 1.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.5 | GO:0034891 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 5.3 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 1.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 1.2 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 2.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 2.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 1.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 2.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 3.9 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 5.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 2.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 2.0 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.2 | GO:0090484 | drug transporter activity(GO:0090484) |
0.1 | 1.3 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.2 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 16.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.3 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.0 | 2.5 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 1.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 1.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 1.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 1.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 1.5 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.0 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.8 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) annealing activity(GO:0097617) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.6 | GO:0019842 | vitamin binding(GO:0019842) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 1.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 2.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.4 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.7 | GO:0051020 | GTPase binding(GO:0051020) |
0.0 | 0.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.7 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.0 | 0.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0032813 | death receptor binding(GO:0005123) tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 1.8 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.6 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.3 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.2 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.4 | GO:0052768 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) retinyl-palmitate esterase activity(GO:0050253) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 15.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 1.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 2.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 1.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.0 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 6.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.6 | 8.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 26.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 17.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 0.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.5 | 17.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.5 | 3.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 11.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 8.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 1.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 14.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 13.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 1.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 2.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 1.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 9.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 2.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 3.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 1.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 5.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 2.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 2.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 1.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 4.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 7.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 9.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 8.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 9.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 5.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 2.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 9.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 1.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 2.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 5.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 2.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 3.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 3.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 3.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 4.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 2.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 3.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 0.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 1.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 3.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 2.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 1.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 0.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 5.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 4.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 9.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 2.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 2.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.4 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 6.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 3.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.9 | 9.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.8 | 8.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 10.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.6 | 7.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 8.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 6.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 1.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 1.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 4.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 3.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 1.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 2.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 8.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 6.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 2.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 2.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 4.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 2.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.4 | 8.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 4.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 9.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 13.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.4 | 3.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 1.4 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.3 | 3.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 4.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 4.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 9.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 8.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 1.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 1.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 4.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 10.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 4.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 8.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 3.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 3.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.3 | 16.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 13.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 0.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 27.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 1.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 3.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 0.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 6.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 2.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 2.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 2.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 11.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 4.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 5.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 3.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 7.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 7.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 1.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 1.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 4.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 0.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 7.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 1.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 1.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 1.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 4.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 2.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 2.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 0.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 1.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 2.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 20.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 1.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 14.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 4.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 2.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 2.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.2 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 2.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 3.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 2.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 2.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 3.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 1.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 1.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 0.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 4.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 3.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 3.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 1.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 1.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 1.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 0.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 1.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 1.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 3.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 1.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 0.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 3.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 2.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 3.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 1.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 3.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 2.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 1.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 3.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 3.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 2.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 1.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.1 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.1 | 2.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 7.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.4 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 2.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 1.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.7 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 1.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 1.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.5 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.7 | REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |